Foreign media commentators have noted that while the Trump administration's latest round of import tariffs may not have a significant short-term impact on the economy, its legal and policy consequences are more noteworthy. The article argues that this approach could transform Section 301 from a targeted tool into a broad taxation instrument that the president can repeatedly invoke.
Previously, the U.S. Supreme Court had rejected Trump's "Liberation Day" tariffs imposed under the International Emergency Economic Powers Act. The government subsequently implemented temporary measures as a transition, switching to a new Section 301 tariff arrangement upon expiration. Since many of these tariffs essentially replaced previously implemented import duties, the market generally believes the short-term impact will be relatively limited.
Commentary focuses on legal precedents
Scott Linc, Vice President of Economics at the Cato Institute, wrote in *The Dispatch* that the government's justification for these tariffs is insufficient. He argues that the tariff rates do not match the actual trade impact of alleged forced labor, and that the policy design lacks a clear exit strategy.
The article further points out that the real risk lies not only in the tariffs themselves, but also in the possibility that they might be tacitly approved by the courts. If the executive branch can initiate investigations and impose high tariffs with weak evidence simply by completing procedural steps, then future presidents may follow the same path.
The scope of Section 301 may be expanded.
Under current rules, Section 301 typically requires an investigation into unfair trade practices before deciding whether to impose tariffs. However, commentators argue that if the investigation process becomes a mere formality, the executive branch could use broader justifications to continuously impose tariffs on different countries and goods.
The article argues that this would deviate the purpose originally intended by Congress for Section 301. Originally intended as a tool for specific trade issues, it could potentially be used for broader topics such as carbon emissions, labor standards, and AI regulation.
The effective tariff rate in the United States is still rising.
In addition to the new tariffs already implemented, the United States has more tariffs in the pipeline. Oxford Economics estimates that the effective tariff rate in the United States will rise from 8.6% to 9.2%, and this figure could rise further to 9.6% after new drug tariffs take effect later this month.
Currently, the United States is also advancing three investigations under Section 301, including investigations into production capacity and manufacturing issues in 16 countries, intellectual property protection issues in Vietnam, and insufficient payment for pharmaceutical innovation in Germany. The article argues that this means there is still room for further tariffs to be imposed.
- Oxford Economics predicts that the effective tariff will first rise to 9.2%.
- After the new tariffs on pharmaceuticals take effect, the tax rate may further rise to 9.6%.
- Three Section 301 investigations are still ongoing in the United States.
The commentary concludes by pointing out that once the Section 301 tariffs become a policy tool that can be quickly escalated and adjusted, both U.S. import costs and business expectations will face greater uncertainty.
